Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including Wegovy and Zepbound are expected to be easier to access and afford. And new options for people averse to needles are coming.

Weight loss can be a challenge, but these people found success with simple steps, leading to dramatic transformations. They share their best advice to lose weight and get healthier.

Celebrities have embraced GLP-1 medications for dramatic weight loss in 2025. Oprah Winfrey, Amy Schumer, Meghan Trainor and Lizzo share their health journeys.

The Wegovy pill is expected to hit the market in January, joining injectable GLP-1 drugs that have transformed obesity treatment. One form you swallow, the other you inject. What else is different?

The National Institute for Health and Care Excellence (Nice), England’s drug approval body, states that adults qualify for treatments such as Mounjaro and Wegovy if they are obese with a body mass index (BMI) of at least 35 and have at least one pre-existing weight-related health conditions.

Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications like Ozempic and Wegovy despite results.